We'd bother with the obvious, but there's no sense in acting exasperated that this thing is finally shipping -- let's just be glad it didn't take a day longer, shall we? Second Sight, a California-based company aiming to help those with degenerative eye disease by way of technology, has finally seen its flagship product approved for "clinical and commercial use" in Europe. The product is the Argus II, and for all intents and purposes, it's a retinal prosthesis (read: implant) that can at least partially restore lost vision. It works a little like this: patients don the camera-laden glasses, where signals are grabbed and fed wirelessly to a chip implanted near on
